In 2010, Prescrire’s Packaging Working Group noted that the box, blister pack and patient information leaflet for DolipraneLib° paracetamol OTC tablets (Rev Prescrire n°325) could not be separated.
This design ensures that the patient information leaflet remains on hand throughout the use of the product, and that a blister pack containing another drug cannot accidentally be put in the box of DolipraneLib° in the family medicine cabinet.
Unfortunately, the printing of the product identifier is systematically spread over 2 blister pockets, each of which contains one 500-mg tablet, a dose that often suffices.
In addition, the information printed on the back of the box does not warn of the risk of serious liver damage when paracetamol is taken at the same time as large quantities of alcohol.
This is why Prescrire was unable to grant the yearly Packaging Award to this product.
©Prescrire 1 June 2011
"2010 drug packaging review: identifying problems to prevent errors" Prescrire Int 2011; 20 (117): 162-165. (pdf, free)